Skip to main content

Table 2 Serum concentrations of hormones before and during treatment

From: Growth and descent of the testes in infants with hypogonadotropic hypogonadism receiving subcutaneous gonadotropin infusion

  Before treatment During treatment
  FSH (UI/l) LH (UI/l) Ta (ng/ml) AMH (pmol/l) INB (pg/ml) FSH (UI/l) LH (UI/l) T (ng/ml) AMH (pmol/l) INB (pg/ml)
Patients with CPHD
P1 0.4 0 0.06 103 5 18 1.2 1 264 55
P2 0.03 <0.1 0.02 675 100 21 2.9 1.4 1644 505
P3 0.61 0.7 0.02 1984 155 18 2 2.8 1040 544
Patients with IHH
P4 1 0.4 0.05 125 91 40 4.6 2.8 29 111
P5 0.8 0.1 0.04 595 73 24 4.7 3.3 565 401
P6 0.1 <0.1 0.05 250 5 41 5.4 3.86 666 287
P7 0.3 <0.1 0.02 665 64 32 4.6 3.9 668 514
P8 0.21 <0.1 0.07 270 14 59 9.5 9.6 890 530
Mean value 0.48 0.15 0.04 583 63.3 31b 4.4b 3.6b 721 368
Normal valuesc 0,2–4 0,5–7,1 0.52–4.8 251–679 254–513 0,2–4 0,5–7,1 0.5–4.8 251–679 254–513
  1. IHH isolated gonadotropin deficiency, CPHD Combined Pituitary Hormonal Deficits (CPHD), INB inhibin B
  2. T testosterone
  3. aTo convert T into SI unit (nmol/l), multiply by 3.47
  4. b p < 0.005 vs baseline values
  5. cRange of normal values taken from reference [18, 19]